Propiedad y actividad de insiders de Pyxis Oncology, Inc. (PYXS): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.34 |
| Capitalización | $212M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-04 | Civik Thomas | A-Award | 2,503,050 | $9.7M |
| 2026-08-20 | Dupont Jakob | A-Award | 46,000 | $144K |
| 2026-08-12 | Civik Thomas | A-Award | 250,956 | $374K |
| 2026-06-30 | GordonMD Global Investments LP | |||
| 2026-06-30 | GordonMD Global Investments LP | 4,900,039 | $16.1M | |
| 2026-06-30 | Dupont Jakob | M-Exempt | 35,000 | $56K |
| 2026-06-30 | Dupont Jakob | M-Exempt | 35,000 | $56K |
| 2026-06-30 | Dupont Jakob | S-Sale | 35,000 | $107K |
| 2026-03-24 | Dupont Jakob | A-Award | 45,867 | $62K |
| 2026-03-24 | Wadhane Jitendra | A-Award | 109,461 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $19.7M | $8.1M | $274.7M | $179.3M | $9.7M | $19.5M | $15.4M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $109.6M | $107.5M | $51.4M |
| Cuentas por Cobrar | 0 | 0 | 0 | $598000 | $21000 | 0 | $700000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $19.7M | $8.1M | $278.7M | $186.6M | $124.6M | $132.4M | $72.1M |
| Inmovilizado Material | $76000 | $1.9M | $1.2M | $24.8M | $24.8M | $22.1M | $19.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | $24.3M | $2.6M | 0 |
| Activos Totales | $19.8M | $10.2M | $280.0M | $211.4M | $173.7M | $157.2M | $91.5M |
| Cuentas por Pagar | $491000 | $1.1M | $12.0M | $7.1M | $3.9M | $4.9M | $10.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $733000 | $3.7M | $18.7M | $31.6M | $25.8M | $17.7M | $21.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $22.7M | $25.8M | $18.7M | $50.6M | $48.0M | $36.4M | $38.1M |
| Reservas | -$2.9M | -$15.7M | -$91.7M | -$212.4M | -$286.2M | -$363.6M | -$443.2M |
| Patrimonio Neto | -$2.9M | -$15.6M | $261.3M | $160.8M | $125.7M | $120.8M | $53.4M |
| Deuda Total | $15000 | $780000 | $165000 | $18.9M | $21.3M | $20.2M | $18.7M |
| Deuda Neta | -$19.7M | -$7.3M | -$274.6M | -$160.4M | -$98.0M | -$106.7M | -$48.2M |
| Capital Circulante | $19.0M | $4.4M | $260.0M | $155.0M | $98.8M | $114.8M | $51.0M |
Salud financiera
| Deuda / Patrimonio | 1.56 |
| Ratio corriente | 1.34 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -7.88 |
Rentabilidad
| Rentabilidad sobre capital | -215.23% |
| Rentabilidad sobre capital invertido | -314.66% |
| Rentabilidad sobre activos | -161.55% |
| Margen bruto | 99.76% |
| Margen operativo | -834.44% |
| Margen neto | -803.83% |
Empresas relacionadas: AVIR · CRBU · ENTA · FHTX · HUMA · IMRX · TNYA
Explorar sector: Healthcare · Biotechnology
Más secciones de PYXS: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones